MansonJE, NathanDM, KrolewskiAS, StampferMJ, WillettWC, HennekensCH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA1992;268:63–7.
2.
HelmrichSP, RaglandDR, LeungRW, PaffenbargerRSJr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med1991;326:147–52.
3.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. JAMA1993;329:977–86.
4.
LewisEJ, HunsickerLG, BainRP, RohdeRD. The effect of angio-tensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med1993: 329;1456–62.
5.
GumsJG, CurryRWJr, Montes De OcaG, SkluthHA, ReynoldsLR. Treatment of type I diabetes with a combination of glyburide and insulin. Ann Pharmacother1992;26:757–62.
6.
MasonJD, ColleyCA. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial. Ann Pharmacother1993;27:555–9.
7.
RuppMT. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother1992;26:1580–4.
8.
MagarianEO, PetersonCD, McCullaghME, KuzelRJ. Role model ambulatory care clinical training site in a community-based pharmacy. Am J Pharm Ed1993;57:1–9.
9.
GoodeMA, GumsJG. Therapeutic drug monitoring in ambulatory care. Ann Pharmacother1993;27:502–5.
10.
GumsJG, RobinsonJD. Pharmacokinetic monitoring in the community health-care setting. Drug Intell Clin Pharm1987;21:422–6.
